Organization

Stanford, CA

10 abstracts

Abstract
Ensuring precision medicine for veterans with lung cancer: A randomized clinical trial.
Org: Morehouse School of Medicine, Atlanta, GA, Stanford University School of Medicine, Stanford, CA, Medical Services,
Abstract
Evaluating disparities in receptor status, overall survival, and time to hormone therapy among women with breast cancer.
Org: Stanford Cancer Institute, Palo Alto, CA, University of Nevada Las Vegas, Las Vegas, NV, Stanford University School of Medicine,
Abstract
A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer (GIANT): ECOG-ACRIN EA2186.
Org: Fox Chase Cancer Center, Dana-Farber Cancer Institute, Wake Forest University Department of General Internal Medicine, Stanford University School of Medicine, ThedaCare Regional Medical Center,
Abstract
Timing of genetic testing referral and genetic testing results in patients with multiple primary cancers.
Org: Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, Palo Alto, CA, Stanford University Department of Psychiatry and Behavioral Sciences,
Abstract
Novel use of alternate (Alt) response (Rp) criteria (Cr) for early prediction of outcomes in pancreatic (P) neuroendocrine tumors (NETs): Utilizing banked imaging data from the ECOG-ACRIN E2211 study.
Org: Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, Yale Cancer Center, Yale School of Medicine, New Haven, CT, New Haven, CT,
Abstract
Examining the potential for lead-time bias by estimating stage-specific proportions of deaths due to diagnosed cancer.
Org: GRAIL, LLC, a subsidiary of Illumina, Inc., Illumina, Inc., Menlo Park, CA, Washington University School of Medicine in St Louis, St. Louis, MO,
Abstract
From the lab to the clinic: Lessons learned from a translational working group.
Org: Duke University School of Medicine, Department of Head and Neck Surgery & Communication Sciences, Durham, NC, Division of Surgical Oncology, Department of Surgery, The Ohio State University, Durham, NC, COMET Study Patient Leadership Team, San Francisco, CA,
Abstract
A multicenter retrospective study of the duration of adjuvant temozolomide in IDH-mutant gliomas.
Org: University of Washington and Fred Hutchinson Cancer Research Centre, School of Medicine, Zhejiang University, Hangzhou, China, Seattle, WA, Stanford Medical Center, Stanford, CA,